<html><body><pre>
[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2934 Introduced in House (IH)]

&lt;DOC&gt;






117th CONGRESS
  1st Session
                                H. R. 2934

To amend title XVIII of the Social Security Act to remove from the list 
 of drugs excluded from coverage under the Medicare prescription drug 
 program prescription oral vitamins and mineral products indicated for 
  the treatment of iron deficiency anemia in individuals with chronic 
                            kidney disease.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 30, 2021

  Mr. O'Halleran (for himself, Mr. Bucshon, Mr. Butterfield, and Mr. 
   Mullin) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to remove from the list 
 of drugs excluded from coverage under the Medicare prescription drug 
 program prescription oral vitamins and mineral products indicated for 
  the treatment of iron deficiency anemia in individuals with chronic 
                            kidney disease.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Renal Anemia Innovation Support and 
Expansion Act'' or the ``RAISE Act''.

SEC. 2. REMOVING CERTAIN PRESCRIPTION VITAMINS AND MINERAL PRODUCTS 
              FROM THE LIST OF DRUGS EXCLUDED FROM COVERAGE UNDER THE 
              MEDICARE PRESCRIPTION DRUG PROGRAM.

    Section 1860D-2(e)(2)(A) of the Social Security Act (42 U.S.C. 
1395w-102(e)(2)(A)) is amended by inserting ``other than subparagraph 
(F) of such section (relating to prescription vitamin and mineral 
products, except prenatal vitamins and fluoride preparations) if the 
prescription vitamin or mineral product is orally administered and is 
indicated for treatment of iron deficiency anemia in individuals with 
chronic kidney disease,'' after ``other than subparagraph (E) of such 
section (relating to smoking cessation agents),''.
                                 &lt;all&gt;
</pre></body></html>
